BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7357406)

  • 41. Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release.
    Nielsen EB; Nielsen M; Braestrup C
    Psychopharmacology (Berl); 1983; 81(1):81-5. PubMed ID: 6415736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Localization of [3H]spiperone binding sites in the intermediate lobe of the rat pituitary gland.
    Lightman SL; Ninkovic M; Hunt SP
    Neurosci Lett; 1982 Oct; 32(2):99-102. PubMed ID: 7145239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
    Creese I; Snyder SH
    Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors.
    Frost JJ; Smith AC; Kuhar MJ; Dannals RF; Wagner HN
    Life Sci; 1987 Mar; 40(10):987-95. PubMed ID: 3821368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat.
    Agnati LF; Benfenati F; Battistini N; Cavicchioli L; Fuxe K; Toffano G
    Acta Physiol Scand; 1983 Feb; 117(2):311-4. PubMed ID: 6869038
    [No Abstract]   [Full Text] [Related]  

  • 46. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat.
    Agnati LF; Fuxe K; Benfenati F; Celani MF; Battistini N; Mutt V; Cavicchioli L; Galli G; Hökfelt T
    Neurosci Lett; 1983 Feb; 35(2):179-83. PubMed ID: 6304577
    [No Abstract]   [Full Text] [Related]  

  • 48. Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats.
    De Blasi A; Mennini T
    Brain Res; 1982 Jun; 242(2):361-4. PubMed ID: 7116143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR; Weinberger S; Segal DS; Creese I
    Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
    Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
    Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
    [No Abstract]   [Full Text] [Related]  

  • 51. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats.
    Bhargava HN
    Eur J Pharmacol; 1984 Apr; 100(1):109-12. PubMed ID: 6723774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes.
    Le Fur G; Phan T; Uzan A
    Life Sci; 1980 Apr; 26(14):1139-48. PubMed ID: 7392792
    [No Abstract]   [Full Text] [Related]  

  • 55. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
    Noguchi-kuno SA; Nakata C; Nishitani H
    Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
    [No Abstract]   [Full Text] [Related]  

  • 56. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL; Thomas WE
    Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain.
    Pedigo NW; Reisine TD; Fields JZ; Yamamura HI
    Eur J Pharmacol; 1978 Aug; 50(4):451-3. PubMed ID: 699968
    [No Abstract]   [Full Text] [Related]  

  • 59. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K; Sato M; Otsuki S
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.